pSb_init containing anti SARS-CoV-2_RBD sybody Sb#16 Citations (5)
Originally described in: Synthetic nanobodies targeting the SARS-CoV-2 receptor-binding domainWalter JD, Hutter CAJ, Zimmermann I, Earp JD, Egloff P, Sorgenfrei M, Hürlimann LM, Gonda I, Meier G, Remm S, Thavarasah S, Plattet P, Seeger MA BioRxiv 2020.04.16.045419 Journal
Articles Citing pSb_init containing anti SARS-CoV-2_RBD sybody Sb#16
| Articles |
|---|
Synthetic nanobody-SARS-CoV-2 receptor-binding domain structures identify distinct epitopes.
Ahmad J, Jiang J, Boyd LF, Natarajan K, Margulies DH.
bioRxiv. 2021 Jan 27. doi: 10.1101/2021.01.27.428466.
PubMed
Associated Plasmids |
Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors.
Landry LG, Anderson AM, Russ HA, Yu L, Kent SC, Atkinson MA, Mathews CE, Michels AW, Nakayama M.
Front Endocrinol (Lausanne). 2021 Mar 25;12:622647. doi: 10.3389/fendo.2021.622647. eCollection 2021.
PubMed
Associated Plasmids |
| Structures of synthetic nanobody-SARS-CoV-2-RBD complexes reveal distinct sites of interaction and recognition of variants. Margulies D, Ahmad J, Jiang J, Boyd L, Zeher A, Huang R, Xia D, Natarajan K. Res Sq. 2021 Jun 16. doi: 10.21203/rs.3.rs-625642/v1. PubMed |
| Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction. Ahmad J, Jiang J, Boyd LF, Zeher A, Huang R, Xia D, Natarajan K, Margulies DH. J Biol Chem. 2021 Oct;297(4):101202. doi: 10.1016/j.jbc.2021.101202. Epub 2021 Sep 16. PubMed |
| Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance. Walter JD, Scherer M, Hutter CAJ, Garaeva AA, Zimmermann I, Wyss M, Rheinberger J, Ruedin Y, Earp JC, Egloff P, Sorgenfrei M, Hurlimann LM, Gonda I, Meier G, Remm S, Thavarasah S, van Geest G, Bruggmann R, Zimmer G, Slotboom DJ, Paulino C, Plattet P, Seeger MA. EMBO Rep. 2022 Apr 5;23(4):e54199. doi: 10.15252/embr.202154199. Epub 2022 Mar 7. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.